Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT06671717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab
ClinicalTrials.gov study NCT04837651. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-Cell Vaccination in Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00220428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT07315087. IPD Sharing: NO. Countries: 1. Publications: 0.
Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
ClinicalTrials.gov study NCT03448978. IPD Sharing: NO. Countries: 1. Publications: 0.
Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
ClinicalTrials.gov study NCT05349890. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
ClinicalTrials.gov study NCT01744223. IPD Sharing: NO. Countries: 1. Publications: 0.
Local Registry of Primary Cutaneous T-cell Lymphomas
ClinicalTrials.gov study NCT07160023. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT01355783. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT06776952. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
ClinicalTrials.gov study NCT02795143. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT00699296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tazemetostat Plus CHOP in 1L T-cell Lymphoma
ClinicalTrials.gov study NCT06692452. IPD Sharing: YES. Countries: 1. Publications: 0.
Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma
ClinicalTrials.gov study NCT05179213. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT06173999. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00363090. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma
ClinicalTrials.gov study NCT06912529. IPD Sharing: NO. Countries: 1. Publications: 0.
Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT04329130. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
ClinicalTrials.gov study NCT06947967. IPD Sharing: NO. Countries: 1. Publications: 0.
CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT02168140. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.